It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A correction to this paper has been published and can be accessed via a link at the top of the paper.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Memorial Sloan Kettering Cancer Center, Myeloma Service, Department of Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
2 Memorial Sloan Kettering Cancer Center, Myeloma Service, Department of Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); Karolinska Institute, Department of Medicine Solna, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
3 Memorial Sloan Kettering Cancer Center, Cytogenetics Laboratory, Department of Pathology, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
4 Memorial Sloan Kettering Cancer Center, Bone Marrow Transplant Service, Department of Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
5 Memorial Sloan Kettering Cancer Center, Center for Hematological Malignancies, Department of Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
6 University of Milan, Department of Oncology and Onco-Hematology, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822); Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Medical Oncology and Hematology, Milan, Italy (GRID:grid.417893.0) (ISNI:0000 0001 0807 2568)
7 Memorial Sloan Kettering Cancer Center, Hematopathology Laboratory, Department of Pathology, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
8 Memorial Sloan Kettering Cancer Center, Center for Hematological Malignancies, Department of Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); Memorial Sloan Kettering Cancer Center, Epidemiology & Biostatistics, Department of Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)